Literature DB >> 34042389

A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.

Rafael Blanco-Domínguez1, Raquel Sánchez-Díaz1, Hortensia de la Fuente1, Luis J Jiménez-Borreguero1, Adela Matesanz-Marín1, Marta Relaño1, Rosa Jiménez-Alejandre1, Beatriz Linillos-Pradillo1, Katerina Tsilingiri1, María L Martín-Mariscal1, Laura Alonso-Herranz1, Guillermo Moreno1, Roberto Martín-Asenjo1, Marcos M García-Guimaraes1, Katelyn A Bruno1, Esteban Dauden1, Isidoro González-Álvaro1, Luisa M Villar-Guimerans1, Amaia Martínez-León1, Ane M Salvador-Garicano1, Sam A Michelhaugh1, Nasrien E Ibrahim1, James L Januzzi1, Jan Kottwitz1, Sabino Iliceto1, Mario Plebani1, Cristina Basso1, Anna Baritussio1, Mara Seguso1, Renzo Marcolongo1, Mercedes Ricote1, DeLisa Fairweather1, Héctor Bueno1, Leticia Fernández-Friera1, Fernando Alfonso1, Alida L P Caforio1, Domingo A Pascual-Figal1, Bettina Heidecker1, Thomas F Lüscher1, Saumya Das1, Valentín Fuster1, Borja Ibáñez1, Francisco Sánchez-Madrid1, Pilar Martín1.   

Abstract

BACKGROUND: The diagnosis of acute myocarditis typically requires either endomyocardial biopsy (which is invasive) or cardiovascular magnetic resonance imaging (which is not universally available). Additional approaches to diagnosis are desirable. We sought to identify a novel microRNA for the diagnosis of acute myocarditis.
METHODS: To identify a microRNA specific for myocarditis, we performed microRNA microarray analyses and quantitative polymerase-chain-reaction (qPCR) assays in sorted CD4+ T cells and type 17 helper T (Th17) cells after inducing experimental autoimmune myocarditis or myocardial infarction in mice. We also performed qPCR in samples from coxsackievirus-induced myocarditis in mice. We then identified the human homologue for this microRNA and compared its expression in plasma obtained from patients with acute myocarditis with the expression in various controls.
RESULTS: We confirmed that Th17 cells, which are characterized by the production of interleukin-17, are a characteristic feature of myocardial injury in the acute phase of myocarditis. The microRNA mmu-miR-721 was synthesized by Th17 cells and was present in the plasma of mice with acute autoimmune or viral myocarditis but not in those with acute myocardial infarction. The human homologue, designated hsa-miR-Chr8:96, was identified in four independent cohorts of patients with myocarditis. The area under the receiver-operating-characteristic curve for this novel microRNA for distinguishing patients with acute myocarditis from those with myocardial infarction was 0.927 (95% confidence interval, 0.879 to 0.975). The microRNA retained its diagnostic value in models after adjustment for age, sex, ejection fraction, and serum troponin level.
CONCLUSIONS: After identifying a novel microRNA in mice and humans with myocarditis, we found that the human homologue (hsa-miR-Chr8:96) could be used to distinguish patients with myocarditis from those with myocardial infarction. (Funded by the Spanish Ministry of Science and Innovation and others.).
Copyright © 2021 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34042389      PMCID: PMC8258773          DOI: 10.1056/NEJMoa2003608

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   176.079


  35 in total

1.  Clinical presentation and diagnosis of myocarditis.

Authors:  Alida L P Caforio; Renzo Marcolongo; Cristina Basso; Sabino Iliceto
Journal:  Heart       Date:  2015-06-24       Impact factor: 5.994

Review 2.  Fourth Universal Definition of Myocardial Infarction (2018).

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White
Journal:  J Am Coll Cardiol       Date:  2018-08-25       Impact factor: 24.094

Review 3.  State of the art: Evaluation and prognostication of myocarditis using cardiac MRI.

Authors:  Michael P Gannon; Ebe Schaub; Cindy L Grines; Shahryar G Saba
Journal:  J Magn Reson Imaging       Date:  2019-01-13       Impact factor: 4.813

4.  MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis.

Authors:  Maarten F Corsten; Anna Papageorgiou; Wouter Verhesen; Paolo Carai; Morten Lindow; Susanna Obad; Georg Summer; Susan L M Coort; Mark Hazebroek; Rick van Leeuwen; Marion J J Gijbels; Erwin Wijnands; Erik A L Biessen; Menno P J De Winther; Frank R M Stassen; Peter Carmeliet; Sakari Kauppinen; Blanche Schroen; Stephane Heymans
Journal:  Circ Res       Date:  2012-06-19       Impact factor: 17.367

5.  MicroRNA‑21 regulation of the progression of viral myocarditis to dilated cardiomyopathy.

Authors:  Hong-Fei Xu; Yu-Jie Ding; Zhi-Xiang Zhang; Zu-Feng Wang; Cheng-Liang Luo; Bei-Xu Li; Yi-Wen Shen; Lu-Yang Tao; Zi-Qin Zhao
Journal:  Mol Med Rep       Date:  2014-05-02       Impact factor: 2.952

6.  Cardiac myosin-Th17 responses promote heart failure in human myocarditis.

Authors:  Jennifer M Myers; Leslie T Cooper; David C Kem; Stavros Stavrakis; Stanley D Kosanke; Ethan M Shevach; DeLisa Fairweather; Julie A Stoner; Carol J Cox; Madeleine W Cunningham
Journal:  JCI Insight       Date:  2016-06-16

7.  Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis.

Authors:  Christos P Kotanidis; Maria-Anna Bazmpani; Anna-Bettina Haidich; Charalambos Karvounis; Charalambos Antoniades; Theodoros D Karamitsos
Journal:  JACC Cardiovasc Imaging       Date:  2018-02-14

8.  Autoimmune myocarditis, valvulitis, and cardiomyopathy.

Authors:  Jennifer M Myers; DeLisa Fairweather; Sally A Huber; Madeleine W Cunningham
Journal:  Curr Protoc Immunol       Date:  2013

9.  Expression of serum microRNA-155 and its clinical importance in patients with heart failure after myocardial infarction.

Authors:  Baojian Zhang; Biao Li; Fen Qin; Fan Bai; Chao Sun; Qiming Liu
Journal:  J Int Med Res       Date:  2019-11-10       Impact factor: 1.671

10.  MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies.

Authors:  Ganna Aleshcheva; Heiko Pietsch; Felicitas Escher; Heinz-Peter Schultheiss
Journal:  ESC Heart Fail       Date:  2020-11-20
View more
  25 in total

1.  Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.

Authors:  Han Zhu; Francisco X Galdos; Daniel Lee; Sarah Waliany; Yuhsin Vivian Huang; Julia Ryan; Katherine Dang; Joel W Neal; Heather A Wakelee; Sunil A Reddy; Sandy Srinivas; Lih-Ling Lin; Ronald M Witteles; Holden T Maecker; Mark M Davis; Patricia K Nguyen; Sean M Wu
Journal:  Circulation       Date:  2022-06-28       Impact factor: 39.918

2.  Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy.

Authors:  Stephane Heymans; James S Ware; Sanjay K Prasad; Amrit S Lota; Mark R Hazebroek; Pantazis Theotokis; Rebecca Wassall; Sara Salmi; Brian P Halliday; Upasana Tayal; Job Verdonschot; Devendra Meena; Ruth Owen; Antonio de Marvao; Alma Iacob; Momina Yazdani; Daniel J Hammersley; Richard E Jones; Riccardo Wage; Rachel Buchan; Fredrik Vivian; Yakeen Hafouda; Michela Noseda; John Gregson; Tarun Mittal; Joyce Wong; Jan Lukas Robertus; A John Baksi; Vassilios Vassiliou; Ioanna Tzoulaki; Antonis Pantazis; John G F Cleland; Paul J R Barton; Stuart A Cook; Dudley J Pennell; Pablo Garcia-Pavia; Leslie T Cooper
Journal:  Circulation       Date:  2022-09-26       Impact factor: 39.918

3.  Resolution of Heart Failure Inflammation.

Authors:  Magnus Bäck
Journal:  JACC Basic Transl Sci       Date:  2022-06-27

4.  The limits of human microRNA annotation have been met.

Authors:  Bastian Fromm; Xiangfu Zhong; Marcel Tarbier; Marc R Friedländer; Michael Hackenberg
Journal:  RNA       Date:  2022-03-02       Impact factor: 5.636

Review 5.  The role of non-coding RNAs in myocarditis: a narrative review.

Authors:  Wenhu Liu; Jing Hu; Shuai Lu; Zhaohui Wang
Journal:  Ann Transl Med       Date:  2022-09

Review 6.  MicroRNA-mediated control of myocardial infarction in diabetes.

Authors:  Daniel Pérez-Cremades; Jingshu Chen; Carmel Assa; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2022-01-17       Impact factor: 8.049

7.  Endothelial-derived extracellular microRNA-92a promotes arterial stiffness by regulating phenotype changes of vascular smooth muscle cells.

Authors:  Chen Wang; Haoyu Wu; Yuanming Xing; Yulan Ye; Fangzhou He; Qian Yin; Yujin Li; Fenqing Shang; John Y-J Shyy; Zu-Yi Yuan
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 8.  A Review on the Evolving Roles of MiRNA-Based Technologies in Diagnosing and Treating Heart Failure.

Authors:  Peter J Kennel; P Christian Schulze
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

9.  Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill Patients.

Authors:  Marta Molinero; Iván D Benítez; Jessica González; Clara Gort-Paniello; Anna Moncusí-Moix; Fátima Rodríguez-Jara; María C García-Hidalgo; Gerard Torres; J J Vengoechea; Silvia Gómez; Ramón Cabo; Jesús Caballero; Jesús F Bermejo-Martin; Adrián Ceccato; Laia Fernández-Barat; Ricard Ferrer; Dario Garcia-Gasulla; Rosario Menéndez; Ana Motos; Oscar Peñuelas; Jordi Riera; Antoni Torres; Ferran Barbé; David de Gonzalo-Calvo
Journal:  Front Med (Lausanne)       Date:  2022-02-03

10.  P2Y12 Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction.

Authors:  Sarah Nasreen Schmidt; Wilfried Reichardt; Beat A Kaufmann; Carolin Wadle; Dominik von Elverfeldt; Peter Stachon; Ingo Hilgendorf; Dennis Wolf; Timo Heidt; Daniel Duerschmied; Karlheinz Peter; Christoph Bode; Constantin von Zur Mühlen; Alexander Maier
Journal:  Cells       Date:  2021-12-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.